Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 26 Oct 2020

Nursing and Allied Health Research Priorities in the Care of Patients With Thoracic Malignancies: An International Cross-Sectional Survey

in Thoracic Oncology

Alex Molassiotis
Anne Fraser
Melissa Culligan
Pippa Labuc
Degi L. Csaba
Andreas Charalambous

Frontiers in Oncology

doi 10.3389/fonc.2020.591799

4,377 views
3 citations

Original Research

Published on 26 Oct 2020

Dual Primary Cancer Patients With Lung Cancer as a Second Primary Malignancy: A Population-Based Study

in Thoracic Oncology

Congkuan Song
Donghu Yu
Yujin Wang
Qingwen Wang
Zixin Guo
Jingyu Huang
Sheng Li
Weidong Hu

Frontiers in Oncology

doi 10.3389/fonc.2020.515606

5,539 views
31 citations

Clinical Trial

Published on 26 Oct 2020

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER

in Thoracic Oncology

Jonathan W. Goldman
Julien Mazieres
Fabrice Barlesi
Konstantin H. Dragnev
Marianna Koczywas
Tuncay Göskel
Alexis B. Cortot
Nicolas Girard
Claas Wesseler
Helge Bischoff

Frontiers in Oncology

doi 10.3389/fonc.2020.578756

11,231 views
47 citations

Systematic Review

Published on 22 Oct 2020

Non-Radiation Based Early Pain Relief Treatment Options for Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: A Systematic Review

in Thoracic Oncology

Anita J. W. M. Brouns
Ben H. De Bie
Marieke H. J. van den Beuken-van Everdingen
Anne-Marie C. Dingemans
Lizza E. L. Hendriks

Frontiers in Oncology

doi 10.3389/fonc.2020.509297

3,119 views
3 citations

Original Research

Published on 22 Oct 2020

ACAA1 Is a Predictive Factor of Survival and Is Correlated With T Cell Infiltration in Non-Small Cell Lung Cancer

in Thoracic Oncology

Huiyi Feng
Weixi Shen

Frontiers in Oncology

doi 10.3389/fonc.2020.564796

6,120 views
11 citations

Original Research

Published on 22 Oct 2020

Overall Survival in Heart Disease–Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study

in Thoracic Oncology

Mohammed Safi
Ravindran Kanesvaran
Mohammed Alradhi
Abdullah Al-Danakh
Feng Ping
Najeeb Al-Sabai
Xiu Shan
Jiwei Liu

Frontiers in Oncology

doi 10.3389/fonc.2020.572380

6,214 views
5 citations

Review

Published on 20 Oct 2020

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors

in Thoracic Oncology

Karam Khaddour
Sandra L. Gomez-Perez
Nikita Jain
Jyoti D. Patel
Yanis Boumber

Frontiers in Oncology

doi 10.3389/fonc.2020.576314

8,923 views
25 citations

Review

Published on 20 Oct 2020

The Resistance Mechanisms of Lung Cancer Immunotherapy

in Thoracic Oncology

Fen Wang
Shubin Wang
Qing Zhou

Frontiers in Oncology

doi 10.3389/fonc.2020.568059

17,762 views
71 citations

Systematic Review

Published on 20 Oct 2020

The Favorable Prognostic Factors for Superior Sulcus Tumor: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Xiaohu Hao
Zihuai Wang
Diou Cheng
Jian Zhou
Nan Chen
Qiang Pu
Lunxu Liu

Frontiers in Oncology

doi 10.3389/fonc.2020.561935

3,978 views
2 citations

Original Research

Published on 19 Oct 2020

Evaluation of the Effect of Lymph Node Status on the Survival of Non-Small Cell Lung Cancer Patients With Brain Metastases: Applications of a Novel Grade Prognostic Assessment Score Model Involving N Stage

in Thoracic Oncology

Jianfei Zhu
Wuping Wang
Shuonan Xu
Chenghui Jia
Qingqing Zhang
Yanmin Xia
Wenchen Wang
Miaomiao Wen
Xuejiao Wang
Hongtao Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.563700

2,622 views
6 citations

Original Research

Published on 15 Oct 2020

Spectrum of Mesenchymal–Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis

in Thoracic Oncology

Juanni Li
Kuan Hu
Lei Zhou
Jinzhou Huang
Shuangshuang Zeng
Zhijie Xu
Yuanliang Yan

Frontiers in Oncology

doi 10.3389/fonc.2020.560615

4,360 views
8 citations

Original Research

Published on 14 Oct 2020

Multiple Immune Features-Based Signature for Predicting Recurrence and Survival of Inoperable LA-NSCLC Patients

in Thoracic Oncology

Meiying Guo
Wanlong Li
Butuo Li
Bing Zou
Shijiang Wang
Bingjie Fan
Xindong Sun
Linlin Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.571380

3,384 views
5 citations

Original Research

Published on 14 Oct 2020

Distinct Subgroups of Patients With Lung Cancer Receiving Chemotherapy: A Latent Transition Analysis

in Thoracic Oncology

Nannan Li
Lili Hou
Shu Li

Frontiers in Oncology

doi 10.3389/fonc.2020.522407

3,409 views
5 citations

Original Research

Published on 14 Oct 2020

Thermal Ablation Versus Wedge Resection for Stage I Non-small Cell Lung Cancer Based on the Eighth Edition of the TNM Classification: A Population Study of the US SEER Database

in Thoracic Oncology

Chenxi Zeng
Jiawei Lu
Yitao Tian
Xiangning Fu

Frontiers in Oncology

doi 10.3389/fonc.2020.571684

4,385 views
24 citations

Original Research

Published on 14 Oct 2020

Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey

in Thoracic Oncology

Chiara Catania
Gianluca Spitaleri
Ester Del Signore
Ilaria Attili
Davide Radice
Valeria Stati
Letizia Gianoncelli
Stefania Morganti
Filippo de Marinis

Frontiers in Oncology

doi 10.3389/fonc.2020.584612

5,294 views
23 citations

Original Research

Published on 09 Oct 2020

Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer

in Thoracic Oncology

Wenxian Wang
Zhangzhou Huang
Zongyang Yu
Wu Zhuang
Weijun Zheng
Zhijian Cai
Lei Shi
Xinmin Yu
Guangyuan Lou
Wei Hong

Frontiers in Oncology

doi 10.3389/fonc.2020.572853

4,620 views
23 citations